Expanding the ethical debate on human artificial placenta trials

Research Ethics 21 (1):9-15 (2025)
  Copy   BIBTEX

Abstract

Artificial placentas (APs) are technologies that mimic the human placenta to treat extremely preterm infants. Being an invasive and risky technology, it will raise important ethical questions for human trials. Hence, in this Topic Piece we provide a blueprint of further issues to investigate. First, counselling will have the double role of providing trial information as well as (non) treatment counselling. This requires extra training and the development of ad hoc decision aids to support counselling and parents’ decision-making. Second, more stakeholder involvement is needed. Direct stakeholders, such as parents, clinicians, and researchers, can help develop the decision aids and provide insight on potentially overlooked issues. Society should also be involved to determine whether AP trials and implementation should be subsidized, and the ethical implications of not subsidizing. Third, a proper cost-benefit analysis should be conducted to determine the exact cost of the technology.

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 103,486

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Clinical trials: two neglected ethical issues.A. Herxheimer - 1993 - Journal of Medical Ethics 19 (4):211-218.

Analytics

Added to PP
2025-01-04

Downloads
1 (#1,956,379)

6 months
1 (#1,580,527)

Historical graph of downloads

Sorry, there are not enough data points to plot this chart.
How can I increase my downloads?